The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease

World Journal of Surgical Oncology

Volumn 5, Issue , 2007, Pages

  Brinkman, Justus Martijn ^a,c   Bron, Johannes L ^a   Wuisman, Paul I J M ^a   van Diest, Paul J ^a,b   Comans, Emile F I ^a   Molthoff, Carla F M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DEVENTER HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; SICKLE CELL ANEMIA; TUMOR LOCALIZATION;

EID: 38049128728     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-5-130     Document Type: Article

References (22)

1. Ferner RE Lucas JD O'Doherty MJ Hughes RA Smith MA Cronin BF Bingham J Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 J Neurol Neurosurg Psychiatry 2000, 68:353-357. 10.1136/jnnp.68.3.353 10675220
2. King AA Debaun MR Riccardi VM Gutmann DH Malignant peripheral nerve sheath tumors in neurofibromatosis 1 Am J Med Genet 2000, 93:388-392. 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-# 10951462
3. Lee J Sohn SK Ahn BC Chun KA Lee K Kim CK Sarcomatous transformation of neurofibromas. Comparative imaging with Ga-67, Tl-201, Tc-99m pentavalent DMSA and Tc-99m MIBI Clin Nucl Med 1997, 22:610-614. 10.1097/ 00003072-199709000-00006 9298294
4. Cardona S Schwarzbach M Hinz U Dimitrakopoulou-Strauss A Attigah N section M Lehnert T Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours Eur J Surg Oncol 2003, 29:536-541. 10.1016/S0748-7983(03)00055-6 12875862
5. Gupta G Maniker A Malignant peripheral nerve sheath tumors Neurosurg Focus 2007, 22:E12. 17613203
6. Solomon SB Semih DA Nicol TL Campbell JN Pomper MG Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis Clin Nucl Med 2001, 26:525-528. 10.1097/ 00003072-200106000-00009 11353300
7. Otsuka H Graham MM Kubo A Nishitani H FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: A case report Ann Nucl Med 2005, 19:55-58. 15770975
8. Bhargava R Parham DM Lasater OE Chari RS Chen G Fletcher BD MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign Pediatr Radiol 1997, 27:124-129. 10.1007/ s002470050082 9028843
9. Scott AM Larson SM Tumor imaging and therapy Radiol Clin North Am 1993, 31:859-879. 8337372
10. Lucas JD O'Doherty MJ Cronin BF Marsden PK Lodge MA McKee PH Smith MA Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography Br J Surg 1999, 86:550-556. 10.1046/j.1365-2168.1999.01090.x 10215835
11. Suga K Hirabayashi A Kishimoto K Kume N Matsumoto T Matsunaga N Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis Clin Nucl Med 1999, 24:435-439. 10.1097/00003072-199906000-00012 10361941
12. Basu S Nair N Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: A case study and review of the literature J Neurooncol 2006, 80:91-95. 10.1007/ s11060-006-9161-x 16850110
13. Brown RS Goodman TM Zasadny KR Greenson JK Wahl RL Expression of hexokinase II and Glut-1 in untreated human breast cancer Nucl Med Biol 2002, 29:443-453. 10.1016/S0969-8051(02)00288-3 12031879
14. Riccardi VM Neurofibromatosis update Neurofibromatosis 1989, 2:284-291. 2518510
15. Kawamura T Kusakabe T Sugino T Watanabe K Fukuda T Nashimoto A Honma K Suzuki T Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival Cancer 2001, 92:634-641. 10.1002/ 1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X 11505409
16. Doorn PF Molenaar WM Buter J Hoekstra HJ Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis Eur J Surg Oncol 1995, 21:78-82. 10.1016/S0748-7983(05)80073-3 7851559
17. Ducatman BS Scheithauer BW Piepgras DG Reiman HM Ilstrup DM Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases Cancer 1986, 57:2006-2021. 10.1002/ 1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6 3082508
18. Evans DG Baser ME McGaughran J Sharif S Howard E Moran A Malignant peripheral nerve sheath tumours in neurofibromatosis 1 J Med Genet 2002, 39:311-314. 10.1136/jmg.39.5.311 12011145
19. Zoller ME Rembeck B Oden A Samuelsson M Angervall L Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population Cancer 1997, 79:2125-2131. 10.1002/ (SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N 9179058
20. Hope DG Mulvihill JJ Malignancy in neurofibromatosis Adv Neurol 1981, 29:33-56. 6798842
21. Mautner VF Brenner W Funsterer C Hagel C Gawad K Friedrich RE Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1 Anticancer Res 2007, 27:1819-1822. 17649778
22. Brenner W Friedrich RE Gawad KA Hagel C von DA de WM Buchert R Clausen M Mautner VF Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours Eur J Nucl Med Mol Imaging 2006, 33:428-432. 10.1007/s00259-005-0030-1 16404595